Literature DB >> 15180251

Proteomic approaches to understanding age-related macular degeneration.

Joe G Hollyfield1, Robert G Salomon, John W Crabb.   

Abstract

Microdissection methods have been developed for isolating drusen and Bruch's membrane from human eyes. Comparative proteomic studies of these isolates from normal and AMD donors were pursued for clues to the biochemical pathways involved in the pathogenesis of AMD. A total of 129 potential drusen proteins were identified by LC MS/MS and immunocytochemical analyses have confirmed drusen localization for approximately 16% of the proteins. The most common drusen proteins appear to be TIMP-3, clusterin, vitronectin and serum albumin. Western blot analysis suggests that carboxyethyl pyrrole-protein adducts derived from docosahexaenoate-containing lipids are more abundant in AMD than in normal tissues. Abnormal protein cross-links and advanced glycation end products were also observed in drusen and Bruch's membrane. Lipid oxidation products and oxidative protein modifications may be causally involved in drusen formation and Bruch's membrane thickening.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 15180251     DOI: 10.1007/978-1-4615-0067-4_11

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  15 in total

Review 1.  Animal models of age related macular degeneration.

Authors:  Mark E Pennesi; Martha Neuringer; Robert J Courtney
Journal:  Mol Aspects Med       Date:  2012-06-15

2.  Isolevuglandins and mitochondrial enzymes in the retina: mass spectrometry detection of post-translational modification of sterol-metabolizing CYP27A1.

Authors:  Casey Charvet; Wei-Li Liao; Gun-Young Heo; James Laird; Robert G Salomon; Illarion V Turko; Irina A Pikuleva
Journal:  J Biol Chem       Date:  2011-04-15       Impact factor: 5.157

3.  Association between systemic arterial stiffness and age-related macular degeneration.

Authors:  Eiichi Sato; Gilbert T Feke; Ephraim Y Appelbaum; Marcel N Menke; Clement L Trempe; J Wallace McMeel
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2006-01-13       Impact factor: 3.117

Review 4.  Dietary hyperglycemia, glycemic index and metabolic retinal diseases.

Authors:  Chung-Jung Chiu; Allen Taylor
Journal:  Prog Retin Eye Res       Date:  2010-09-22       Impact factor: 21.198

5.  Receptor-Mediated Mechanism Controlling Tissue Levels of Bioactive Lipid Oxidation Products.

Authors:  Young-Woong Kim; Valentin P Yakubenko; Xiaoxia Z West; Gabriel B Gugiu; Kutralanathan Renganathan; Sudipta Biswas; Detao Gao; John W Crabb; Robert G Salomon; Eugene A Podrez; Tatiana V Byzova
Journal:  Circ Res       Date:  2015-05-12       Impact factor: 17.367

Review 6.  Isolevuglandin adducts in disease.

Authors:  Robert G Salomon; Wenzhao Bi
Journal:  Antioxid Redox Signal       Date:  2015-02-18       Impact factor: 8.401

7.  A hapten generated from an oxidation fragment of docosahexaenoic acid is sufficient to initiate age-related macular degeneration.

Authors:  Joe G Hollyfield; Victor L Perez; Robert G Salomon
Journal:  Mol Neurobiol       Date:  2010-03-12       Impact factor: 5.590

8.  Carboxyethylpyrroles: From Hypothesis to the Discovery of Biologically Active Natural Products.

Authors:  Robert G Salomon
Journal:  Chem Res Toxicol       Date:  2016-11-02       Impact factor: 3.739

Review 9.  Immunology of age-related macular degeneration.

Authors:  Jayakrishna Ambati; John P Atkinson; Bradley D Gelfand
Journal:  Nat Rev Immunol       Date:  2013-06       Impact factor: 53.106

Review 10.  Vascular endothelial growth factor in eye disease.

Authors:  J S Penn; A Madan; R B Caldwell; M Bartoli; R W Caldwell; M E Hartnett
Journal:  Prog Retin Eye Res       Date:  2008-05-28       Impact factor: 21.198

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.